ResearcherRush University Medical CenterNo recent work listed
William Leslie
Matched on OpenAlex author ID A5103442144, A5108262240. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2012: 1 paper · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper
Papers 3
- A Patient with Metastatic Microsatellite Instability-High Pancreatic Ductal Adenocarcinoma with a Prolonged Response to Single-Agent Pembrolizumab. Last author DOI 10.1159/000519181↗
- Prognostic significance of carbohydrate antigen 19-9 in unresectable locally advanced pancreatic cancer treated with dose-escalated intensity modulated radiati… Co-author DOI 10.1016/j.ijrobp.2012.11.020↗
- A phase I/II trial of intensity modulated radiation (IMRT) dose escalation with concurrent fixed-dose rate gemcitabine (FDR-G) in patients with unresectable pa… Co-author DOI 10.1016/j.ijrobp.2012.02.051↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Annie A. Guedikian · 1 shared paper, 2021 · strength 0.19
- Theodore Steven Lawrence · 2 shared papers, 2012–2013 · strength 0.06
- Paper Prognostic significance of carbohydrate antigen 19-9 in unresectable locally advanced pancreatic cancer treated with do… DOI 10.1016/j.ijrobp.2012.11.020↗
- Paper A phase I/II trial of intensity modulated radiation (IMRT) dose escalation with concurrent fixed-dose rate gemcitabine … DOI 10.1016/j.ijrobp.2012.02.051↗
- Ross Allen Abrams · 2 shared papers, 2012–2013 · strength 0.06
- Paper Prognostic significance of carbohydrate antigen 19-9 in unresectable locally advanced pancreatic cancer treated with do… DOI 10.1016/j.ijrobp.2012.11.020↗
- Paper A phase I/II trial of intensity modulated radiation (IMRT) dose escalation with concurrent fixed-dose rate gemcitabine … DOI 10.1016/j.ijrobp.2012.02.051↗
- Edgar Ben‐Josef · 2 shared papers, 2012–2013 · strength 0.06
- Paper Prognostic significance of carbohydrate antigen 19-9 in unresectable locally advanced pancreatic cancer treated with do… DOI 10.1016/j.ijrobp.2012.11.020↗
- Paper A phase I/II trial of intensity modulated radiation (IMRT) dose escalation with concurrent fixed-dose rate gemcitabine … DOI 10.1016/j.ijrobp.2012.02.051↗
- Isaac R. Francis · 2 shared papers, 2012–2013 · strength 0.06
- Paper Prognostic significance of carbohydrate antigen 19-9 in unresectable locally advanced pancreatic cancer treated with do… DOI 10.1016/j.ijrobp.2012.11.020↗
- Paper A phase I/II trial of intensity modulated radiation (IMRT) dose escalation with concurrent fixed-dose rate gemcitabine … DOI 10.1016/j.ijrobp.2012.02.051↗
- Mark M. Zalupski · 2 shared papers, 2012–2013 · strength 0.06
- Paper Prognostic significance of carbohydrate antigen 19-9 in unresectable locally advanced pancreatic cancer treated with do… DOI 10.1016/j.ijrobp.2012.11.020↗
- Paper A phase I/II trial of intensity modulated radiation (IMRT) dose escalation with concurrent fixed-dose rate gemcitabine … DOI 10.1016/j.ijrobp.2012.02.051↗
- Gazala Naaz Khan · 2 shared papers, 2012–2013 · strength 0.06
- Paper Prognostic significance of carbohydrate antigen 19-9 in unresectable locally advanced pancreatic cancer treated with do… DOI 10.1016/j.ijrobp.2012.11.020↗
- Paper A phase I/II trial of intensity modulated radiation (IMRT) dose escalation with concurrent fixed-dose rate gemcitabine … DOI 10.1016/j.ijrobp.2012.02.051↗
- Jeffrey M. Vainshtein · 1 shared paper, 2013 · strength 0.04
- Diane M. Simeone · 1 shared paper, 2012 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.